← All FR Documents
NoticeProcedural — Withdrawal

Pfizer Inc., U.S. Agent for King Pharmaceuticals LLC, et al.; Withdrawal of Approval of 20 Abbreviated New Drug Applications

In Plain English

What is this Federal Register notice?

This is a notice published in the Federal Register by Health and Human Services Department, Food and Drug Administration. Notices communicate information, guidance, or policy interpretations but may not create new binding obligations.

Is this rule final?

This document is classified as a notice. It may or may not create enforceable regulatory obligations depending on its specific content.

Who does this apply to?

Consult the full text of this document for specific applicability provisions. The affected parties depend on the regulatory scope defined within.

When does it take effect?

No specific effective date is indicated. Check the full text for date provisions.

Why it matters: This rule withdraws a previously issued regulatory action affecting applicable regulations.

Document Details

Document Number2025-22683
TypeNotice
PublishedDec 12, 2025
Effective Date-
RIN-
Docket IDDocket No. FDA-2025-N-6077
Text FetchedNo

Agencies & CFR References

CFR References:
None

Linked CFR Parts

PartNameAgency
No linked CFR parts

Paired Documents

TypeProposedFinalMethodConf
No paired documents

External Links

Full Text

Text Not Yet Fetched

The full text for this document hasn't been fetched yet. The system will automatically retrieve it during the next processing cycle.